Literatur und Quellen

  1. Afrin LB, Molderings GJ (2014). A concise, practical guide to diagnostic assessment for mast cell activation disease. World Journal of Hematology, 3(1), S. 1-17. doi:10.5315/wjh.v3.i1.1.

  2. Afrin LB, Self S, Menk J, Lazarchick J (2017). Characterization of Mast Cell Activation Syndrome. The American Journal of the Medical Sciences, 353(3), S. 207-215. doi:10.1016/j.amjms.2016.12.013. Volltext frei verfügbar: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341697/

  3. Afrin LB, Pöhlau D, Raithel M, Haenisch B, Dumoulin FL, Homann J, Mauer UM, Harzer S, Molderings GJ (2015). Mast cell activation disease: An underappreciated cause of neurologic and psychiatric symptoms and diseases. Brain, Behavior, and Immunity, 50, S. 314-321. doi: 10.1016/j.bbi.2015.07.002. Abstract hier verfügar: https://www.ncbi.nlm.nih.gov/pubmed/26162709

  4. Afrin LB (2013). Presentation, Diagnosis, and Management of Mast Cell Activation Syndrome. Mast Cells: Phenotypic Features, Biological Functions, and Role in Immunity. Happauge, NY: Nova Science Publishers, S. 155-231. Volltext frei verfügbar: www.jillcarnahan.com/downloads/MCAS-Afrin.pdf

  5. Afrin LB (2014). The Presentation, Diagnosis and Treatment of Mast Cell Activation Syndrome. Current Allergy & Clinical Immunology, 27(3), S. 146-160.

  6. Molderings GJ, Homann J, Brettner S, Raithel M, Frieling T (2014). Systemische Mastzellaktivierungserkrankung: Ein praxisorientierter Leitfaden zu Diagnostik und Therapie. Deutsche Medizinische Wochenschrift, 139(30), S. 1523-1538. doi: 10.1055/s-0034-1370055. Abstract hier verfügbar: https://www.ncbi.nlm.nih.gov/pubmed/24801454

  7. MCAS-Diagnostikcheckliste Uni Bonn, https://www.humangenetics.uni-bonn.de/de/forschung/forschungsprojekte/mastzellerkrankungen/checklistepatientenversion

  8. Morris ZS, Wooding S, Grant J (2011). The answer is 17 years, what is the question: understanding time lags in translational research. Journal of the Royal Society of Medicine, 104(12), S. 510–520. doi: 10.1258/jrsm.2011.110180. Volltext frei verfügbar: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241518/   

  9. Afrin LB (2016). Never Bet Against Occam: Mast Cell Activation Disease and The Modern Epidemic of Chronic Illness and Medical Complexity. Bethesda, Maryland: Sisters Media. Chapter 25: Treatment of MCAS. Hier kannst du das Buch bei Amazon kaufen: https://amzn.to/2QOGw2B Falls du es über diesen Link kaufst, bekomme ich eine kleine Provision. Für dich kostet das nichts extra.

  10. Molderings GJ, Haenisch B, Brettner S, Homann J, Menzen M, Dumoulin FL, Panse J, Butterfield J, Afrin LB (2016). Pharmacological treatment options for mast cell activation disease. Naunyn-Schmiedeberg's Archives of Pharmacology, 389, S. 671-694, DOI 10.1007/s00210-016-1247-1. Volltext frei verfügbar: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903110/

  11. Zhang T, Finn DF, Barlow JW, Walsh JJ (2016). Mast cell stabilisers. European Journal of Pharmacology, 778, S. 158-168. doi: 10.1016/j.ejphar.2015.05.071. Epub 2015 Jun 27. Abstract hier verfügbar: https://www.ncbi.nlm.nih.gov/pubmed/26130122

  12. Skaper SD, Facci L, Zusso M, Giusti P (2018). An Inflammation-Centric View of Neurological Disease: Beyond the Neuron. Frontiers in Cellular Neuroscience, 12, 72. doi: 10.3389/fncel.2018.00072. Volltext frei verfügbar: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871676/

  13. Foods With the Highest Content of Quercetin, Jody Braverman, updated December 20, 2019, https://www.livestrong.com/article/301326-foods-with-the-highest-content-of-quercetin/

  14. Peritore AF, Siracusa R, Crupi R, Cuzzocrea S (2019). Therapeutic Efficacy of Palmitoylethanolamide and Its New Formulations in Synergy with Different Antioxidant Molecules Present in Diets. Nutrients, 11(9). pii: E2175. doi: 10.3390/nu11092175. Volltext frei verfügbar: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769461/

  15. USDA/Agricultural Research Service. (2010, July 16). Luteolin stars in study of healthful plant compounds. ScienceDaily, Abgerufen am 27. März 2020, www.sciencedaily.com/releases/2010/07/100708141622.htm

  16. Finn DF, Walsh JJ (2013). Twenty-first century mast cell stabilizers. British Journal of Pharmacology, 170(1), 23–37. doi: 10.1111/bph.12138. Volltext frei verfügbar: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764846/

  17. Afrin LB, Ackerley MB, Bluestein LS, Brewer JH, Brook JB, Buchanan AD, Cuni JR, Davey WP, Dempsey TT, Dorff SR, Dubravec MS, Guggenheim AG, Hindman KJ, Hoffman B, Kaufman DL, Kratzer SJ, Lee TM, Marantz MS, Maxwell AJ, McCann KK, McKee DL, Menk Otto L, Pace LA, Perkins DD, Radovsky L, Raleigh MS, Rapaport SA, Reinhold EJ, Renneker ML, Robinson WA, Roland AM, Rosenbloom ES, Rowe PC, Ruhoy IS, Saperstein DS, Schlosser DA, Schofield JR, Settle JE, Weinstock LB, Wengenroth M, Westaway M, Xi SC, Molderings GJ (2020). Diagnosis of mast cell activation syndrome: a global "consensus-2". Diagnosis (Berl). pii: /j/dx.ahead-of-print/dx-2020-0005/dx-2020-0005.xml. doi: 10.1515/dx-2020-0005. Volltext frei verfügbar: https://www.degruyter.com/view/journals/dx/ahead-of-print/article-10.1515-dx-2020-0005/article-10.1515-dx-2020-0005.xml

  18. COPE, Ibelgaufts H, http://www.cells-talk.com/ Cytokines & Cells Online Pathfinder Encyclopaedia, Version 50.9 (Spring 2020 Edition). Molekularbiologische Datenbank.

on social media

  • Facebook Social Icon
  • zwitschern
  • Instagram
  • RSS Social Icon

Suche

Noch Fragen?

Adressen

Mitgliedschaften

ist Mitglied bei

Mitmachen!

Inhaltsverzeichnis

1.

Newsletteranmeldung

Service

Rechtliches

  • Facebook
  • Twitter
  • Instagram
  • Schwarz RSS Icon

ist Mitglied bei